In his State of the Union address, President Donald Trump urged Congress to pass a controversial bill promising greater access to untested drugs for terminally ill patients. But critics charge the bill would only deliver false hope and result in even less patient protection by removing FDA oversight.
After a federal official told staff not to use certain words in budget documents, the pushback was huge. But there might have been a method to this madness.
“Right to Try” legislation would allow pharmaceutical companies to give experimental drugs to desperate patients — with no chance of being liable if things go wrong. Supporters of the measure cheer this approach but critics see dangers.
Now that ebola hysteria has stopped interrupting regular programming and the American patients are cured, the risk is gone, right? Not so fast …